EcoDrugPlus

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSDARG00000029501
Gene Symbol: GSK3AA
5 Cross references
181 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSDARG00000015681
Gene Symbol: GSK3AB
5 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSDARG00000017803
Gene Symbol: GSK3BA
21 Enzyme and pathways 5 Cross references
209 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate B

Ensembl ID : ENSDARG00000052468
Gene Symbol: GSK3BB
5 Cross references
161 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor 1

Ensembl ID : ENSDARG00000100593
Gene Symbol: GNRHR1
7 Enzyme and pathways 5 Cross references
174 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor, Like

Ensembl ID : ENSDARG00000095788
Gene Symbol: GHRHRL
7 Enzyme and pathways 3 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor A

Ensembl ID : ENSDARG00000056230
Gene Symbol: GHSRA
4 Enzyme and pathways 5 Cross references
196 Possible Orthologues:

Growth Hormone Secretagogue Receptor B

Ensembl ID : ENSDARG00000057117
Gene Symbol: GHSRB
5 Cross references
200 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSDARG00000013787
Gene Symbol: GUCY1A1
5 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSDARG00000093185
Gene Symbol: GUCY1A2
6 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSDARG00000086790
Gene Symbol: GUCY1B1
5 Cross references
211 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class A Member 1, Tandem Duplicate 1

Ensembl ID : ENSDARG00000010478
Gene Symbol: HSP90AA1.1
5 Cross references
305 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).